Zhe Xu

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 4

Top Topics

Epithelial Mesenchymal Transition

Top Venues

Future oncology (London, England)

Science translational medicine

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Yonggang Li, Zhe Xu, Yuanyuan Li, Tianjun Jiang, Fanping Meng, Junliang Fu, Lei Huang, Fengchao Wang, Xia Wang, Fu-Sheng Wang
Preclinical and phase I studies of an antisense oligonucleotide drug targeting IGF-1R in liver cancer. Future oncology (London, England) (2024)
Yonggang Li, Zhe Xu, Yuanyuan Li, Tianjun Jiang, Fanping Meng, Junliang Fu, Lei Huang, Fengchao Wang, Xia Wang, Fu-Sheng Wang
Preclinical and phase I studies of an antisense oligonucleotide drug targeting IGF-1R in liver cancer. Future oncology (London, England) (2024)
Xiao-Kun Li, Qing-Bin Lu, Wei-Wei Chen, Wen Xu, Rong Liu, Shao-Fei Zhang, Juan Du, Hao Li, Ke Yao, Di Zhai, Pan-He Zhang, Bo Xing, Ning Cui, Zhen-Dong Yang, Chun Yuan, Xiao-Ai Zhang, Zhe Xu, Wu-Chun Cao, Ze-Ping Hu, Wei Liu
Arginine deficiency is involved in thrombocytopenia and immunosuppression in severe fever with thrombocytopenia syndrome. Science translational medicine 10 (459) (2019)
Zhe Xu, Shaojun Xing, Qiang Shan, Jodi A Gullicksrud, Thomas B Bair, Yubin Du, Chengyu Liu, Hai-Hui Xue
Cutting Edge: β-Catenin-Interacting Tcf1 Isoforms Are Essential for Thymocyte Survival but Dispensable for Thymic Maturation Transitions. Journal of immunology (Baltimore, Md. : 1950) 198 (9) (2017)